Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study
Author(s):
Schaik, I. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; Lawo, J.P.; Mielke, O.; Durn, B.L.; Cornblath, D.R.; Merkies, I.S.; Path Study Grp
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-07-31
Language
English
Is part of
European Journal of Neurology (2017), Vol. 24, p. 30-30
